How many studies have been conducted on Growth Arrest Specific Protein 6?

BiohacksAI has indexed 161 PubMed studies on Growth Arrest Specific Protein 6, including 1 randomized controlled trials (RCTs). 42% of studies involve human subjects.

What are the main research areas for Growth Arrest Specific Protein 6?

The primary research domains for Growth Arrest Specific Protein 6 are 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity. This is based on analysis of 161 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Growth Arrest Specific Protein 6

A ligand for RECEPTOR PROTEIN-TYROSINE KINASES AXL, TYRO3 and MERTK through which it regulates cell growth and survival of ENDOTHELIAL CELLS; CELL ADHESION; and CELL MIGRATION. GAS6 also has critical roles in the development of NATURAL KILLER CELLS and PLATELET ACTIVATION.

161+ PubMed studies analyzed · 1 RCTs · Evidence Score: 49.9

Research Domains

Growth Arrest Specific Protein 6 has been studied across 19 research domains including 🔬 Oncology, 🔬 Inflammation, 🛡️ Immunity, 🫘 Kidney, 🔥 Metabolic. The primary research focus is 🔬 Oncology with 25% of studies addressing this area.

Loading evidence profile...

This evidence profile for Growth Arrest Specific Protein 6 is generated deterministically from 161 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.